🩺 Closing the Gap: Strengthening Europe’s Path to Timelier, Fairer Dementia Diagnosis
Have you ever wondered what happens when someone walks into their GP surgery worried about their memory - and whether that first step toward a dementia diagnosis looks the same across Europe?
Photo: Colourbox.com
These questions sit at the heart of our new report, which examines the clinical guidelines that shape how clinicians today navigate one of the most complex challenges in modern healthcare: identifying the early signs of cognitive decline with confidence and accuracy, and knowing the right next steps to take.
In the recent work by Work Package 5, our researchers confirm what many clinicians already experience daily. Primary care is the first port of call for most people who notice memory changes or other cognitive concerns, but clinical guidelines aimed at primary care often lack the practical detail needed for day-to-day decision making. Guidelines across Europe broadly agree on essential components—history‑taking, cognitive testing, identifying reversible causes—but rarely provide the practical detail clinicians need, such as which tools to use, how to sequence assessments, or when to refer patients for specialist evaluation. This lack of clarity contributes to wide variations in practice and can contribute to delays before people receive a diagnosis
Despite these challenges, the insights we gathered are encouraging. Across Europe, healthcare professionals expressed enthusiasm for innovations that can streamline assessment and reduce diagnostic uncertainty. Many voiced strong supports for approaches that are scalable and easy to integrate into everyday clinical workflows. This sense of momentum is especially important as new diagnostic technologies continue to emerge.
In this context, the PREDICTOM digital platform represents a particularly exciting step forward. By enabling individuals to complete cognitive tests and even biomarker assessments from home—including a simple finger‑prick blood test—PREDICTOM has the potential to transform the diagnostic pathway. Such tools can equip GPs with richer information earlier in the process, reduce unnecessary referrals, and help ensure that those at higher risk reach specialist services more quickly. Importantly, they also offer a gentler, more accessible entry point for patients who may otherwise hesitate to seek help.
Ultimately, at the heart of this report is a simple truth: clear, timely and compassionate dementia diagnosis has the power to change lives. It allows families to plan, to understand what they are facing, and to access the support they need. It provides clinicians with a foundation for meaningful conversations and personalised care. And it strengthens our collective ability to respond to one of the most pressing public health challenges of our time.
Our findings underscore the importance of continued investment in dementia research and diagnostic innovation. With shared commitment—from clinicians, researchers, policymakers, and communities—we can build a future where people with cognitive concerns can access a clear, consistent, and supportive route to assessment and care. A system where timely assessment is routine, not the exception.
Photo: Colourbox.com
